Abstract
To identify key oncogenes and proteins that are controlled by the microRNA miR-29 family (miR-29a, miR-29b and miR-29c) in renal cell carcinoma pathogenesis. Genome-wide gene expression and in silico database analyses were carried out. The Cancer Genome Atlas database was used to investigate the clinical significance of gene expression data in renal cell carcinoma patients. Loss-of-function assays were applied to investigate the function of target genes. We identified 47 possible target genes that might be regulated by the miR-29 family in renal cell carcinoma cells. Among the targets of the miR-29 family, high expression of 10 genes (ADAMTS14, TRIB13, SERPINH1, FCGR1B, COL1A1, LAIR2, WISP2, TREM1, TNKS1BP1 and GBP2) significantly predicted poor patient prognosis (P < 0.001). SERPINH1 was directly regulated by the miR-29 family, and its overexpression was detected in renal cell carcinoma surgical specimens and tyrosine kinase inhibitor failure autopsy specimens. High expression of SERPINH1 was significantly associated with tumor stage, pathological grade and poor prognosis (P < 0.0001). Knockdown assays showed that its expression enhanced cancer cell migration and invasive abilities. Genes regulated by the anti-tumor miR-29 fam...Continue Reading
References
Mar 25, 2006·Nature Reviews. Cancer·Aurora Esquela-Kerscher, Frank J Slack
Mar 4, 2008·Cancer Treatment Reviews·Kiran GuptaClaudie Charbonneau
Oct 29, 2008·Genome Research·Robin C FriedmanDavid P Bartel
Nov 19, 2011·Journal of the American Society of Nephrology : JASN·Bo WangPhillip Kantharidis
May 17, 2012·Cancer Discovery·Ethan CeramiNikolaus Schultz
Jul 24, 2012·The Journal of Urology·Robert FiglinChristopher G Wood
Jan 15, 2013·Cancer Research·Constance BaerChristoph Plass
Jan 30, 2013·European Journal of Cell Biology·Yang WangXiubao Ren
Apr 4, 2013·Science Signaling·Jianjiong GaoNikolaus Schultz
Oct 22, 2013·International Journal of Oncology·Noriko YamamotoNaohiko Seki
Feb 28, 2014·Oncology Reports·Hesong JiangChun-Ping Jiang
Jan 21, 2015·International Journal of Urology : Official Journal of the Japanese Urological Association·Yusuke GotoNaohiko Seki
Mar 7, 2015·Cancer Research·Jieqing ZhuRen Xu
Jun 23, 2015·FEBS Letters·Rika NishikawaNaohiko Seki
Dec 19, 2015·Oncoscience·Ren Xu
Jan 19, 2016·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Cheryl M KohErnesto Guccione
Mar 18, 2016·International Journal of Oncology·Akira KurozumiNaohiko Seki
Aug 4, 2016·Oncotarget·Yusuke GotoNaohiko Seki
Aug 5, 2016·Journal of Human Genetics·Kazuto KamikawajiHiromasa Inoue
Feb 16, 2017·Oncotarget·Joan ChangThomas R Cox
Apr 19, 2017·Oncotarget·Keiichi KoshizukaNaohiko Seki
Jun 10, 2017·Journal of the National Comprehensive Cancer Network : JNCCN·Robert J MotzerRashmi Kumar
Jun 15, 2017·Cancer Science·Keiichi KoshizukaNaohiko Seki
Jun 24, 2017·British Journal of Cancer·Yusuke GotoNaohiko Seki
Dec 29, 2017·Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada·Mauricio Medina-RicoJuan Guillermo Prada
Feb 9, 2018·Cancer Science·Yasutaka YamadaNaohiko Seki
Feb 10, 2018·Oncotarget·Keiichi KoshizukaNaohiko Seki
Citations
Mar 1, 2019·International Journal of Urology : Official Journal of the Japanese Urological Association·Takayuki AraiNaohiko Seki
Jun 15, 2019·Molecular Oncology·Yasutaka YamadaNaohiko Seki
Nov 23, 2019·Molecular Oncology·Hiroko TodaShoji Natsugoe
Jan 14, 2020·The Anatomical Record : Advances in Integrative Anatomy and Evolutionary Biology·Xiaoqiu YangZhiwu Han
Jan 25, 2020·Cancer Science·Yasutaka YamadaNaohiko Seki
Jul 25, 2019·Cancer Cell International·Li-Juan TangJiang Lin
Aug 15, 2019·Aging·Jing ChenXian Wang
May 6, 2019·Cancers·Shunsuke MisonoHiromasa Inoue
Mar 15, 2019·Cancers·Muhammad KhalidShoji Natsugoe
Mar 13, 2019·Journal of Human Genetics·Haruhi FukuhisaShoji Natsugoe
Apr 3, 2020·Journal of Human Genetics·Kosuke KawagoeNaohiko Seki
Mar 1, 2019·Cancers·Akifumi UchidaHiromasa Inoue
Nov 11, 2020·Bioscience Reports·Wei HanGuo-Liang Shen
Jan 28, 2021·Cancers·Tamsin Joy RobbCherie Blenkiron
Apr 17, 2021·BioMed Research International·Siwei BiJun Gu
Jul 6, 2021·PeerJ·Zhenjun JiGenshan Ma